| Literature DB >> 25846547 |
Takeshi Tomiyama1, Shin-ichiro Kumita, Keiichi Ishihara, Masaya Suda, Minoru Sakurai, Kenta Hakozaki, Hidenobu Hashimoto, Naoto Takahashi, Hitoshi Takano, Yasuhiro Kobayashi, Tomonari Kiriyama, Yoshimitsu Fukushima, Wataru Shimizu.
Abstract
To assess the effect of adenosine infusion by evaluating the relationship between heart rate (HR) response to adenosine and myocardial flow reserve (MFR) of remote regions supplied by normal coronary arteries in (13)N-ammonia PET. Thirty-one consecutive subjects (20 known coronary artery disease patients, 4 chronic heart failure patients, and 7 normal volunteers) except cases having 3-vessel disease underwent rest and adenosine stress (13)N-ammonia myocardial perfusion PET. Semi-quantitative, quantitative, and gated analyses were performed. Subjects were divided into two groups with regard to HR response to adenosine. Twenty-two subjects had normal HR response (peak/rest HR > 1.20), while reduced HR response (≤ 1.20) was observed in nine subjects. There were no differences in rest myocardial blood flow (MBF) of remote regions between the groups. Subjects with reduced HR response had significantly lower stress MBF and MFR of remote regions than those with normal HR response (stress MBF: 1.559 ± 0.517 vs. 2.279 ± 0.530, p = 0.004, MFR: 1.59 ± 0.36 vs. 2.35 ± 0.53, p = 0.001). There were no significant differences between the groups by means of semi-quantitative scoring. Rest and stress ejection fraction (EF) in the reduced HR response group was lower than that in the normal HR response group. In a multiple stepwise regression analysis, HR ratio, dyslipidemia, and Brinkman index were identified as predictors of the change in MFR of remote regions. Subjects with reduced HR response to adenosine had lower stress MBF and MFR of remote regions and lower EF. Moreover, HR response was one of the predictors of the change in MFR of remote regions.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25846547 PMCID: PMC4446519 DOI: 10.1007/s10554-015-0654-6
Source DB: PubMed Journal: Int J Cardiovasc Imaging ISSN: 1569-5794 Impact factor: 2.357
Baseline characteristics according to normal or reduced heart rate ratio
| Normal HRR (n = 22) | Reduced HRR (n = 9) |
| |
|---|---|---|---|
| Gender (male) | 14 (63.6 %) | 8 (88.9 %) | 0.160 |
| Age (y/o) | 65.5 ± 11.8 | 68.2 ± 11.5 | 0.571 |
| Body mass index (kg/m2) | 23.7 ± 3.9 | 22.6 ± 4.2 | 0.572 |
| Hypertension | 15 (68.2 %) | 7 (77.8 %) | 0.593 |
| Diabetes mellitus | 9 (40.9 %) | 3 (33.3 %) | 0.694 |
| Dyslipidemia | 14 (63.6 %) | 6 (66.7 %) | 0.873 |
| Hemodialysis | 1 (4.5 %) | 2 (22.2 %) | 0.131 |
| eGFR (ml/min/1.73 m2) | 70.3 ± 21.8 | 56.3 ± 31.5 | 0.499 |
| Smoking | |||
| Present smoker | 2 (9.1 %) | 0 (0 %) | |
| Past smoker | 7 (31.8 %) | 8 (88.9 %) | 0.015 |
| Never | 13 (59.1 %) | 1 (11.1 %) | |
| Brinkman index | 471.4 ± 726.8 | 553.3 ± 403.3 | 0.157 |
| Coronary stenosis | |||
| 2-vessel | 9 (40.9 %) | 3 (33.3 %) | |
| 1-vessel | 6 (27.3 %) | 2 (22.2 %) | 0.801 |
| 0-vessel | 7 (31.8 %) | 4 (44.4 %) | |
| Prior PCI | 4 (18.2 %) | 1 (11.1 %) | 0.627 |
| β-blocker | 7 (31.8 %) | 6 (66.7 %) | 0.074 |
| Ca-blocker | 11 (50.0 %) | 5 (55.6 %) | 0.779 |
| ACE-inh or ARB | 12 (54.5 %) | 5 (55.6 %) | 0.959 |
| Symptom | |||
| Typical chest pain | 3 (13.6 %) | 0 (0 %) | |
| Atypical chest pain | 5 (22.7 %) | 2 (22.2 %) | 0.492 |
| Asymptomatic | 14 (63.6 %) | 7 (77.8 %) | |
Subjects with reduced HR response frequently had a smoking habit and tended to take β-blocker. HRR heart rate response, eGFR estimated glomerular filtration rate, PCI percutaneous coronary intervention, ACE-Inh angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker
Hemodynamic responses to adenosine, myocardial perfusion, and gated PET analyses in normal and reduced heart rate response (HRR) groups
| Variable | Normal HRR (n = 22) | Reduced HRR (n = 9) |
|
|---|---|---|---|
| Rest HR (bpm) | 64.7 ± 7.6 | 73.3 ± 10.4 | 0.041 |
| Peak HR (bpm) | 88.0 ± 10.0 | 82.9 ± 11.5 | 0.305 |
| Heart rate ratio | 1.37 ± 0.12 | 1.13 ± 0.03 | <0.001 |
| Rest mean BP (mmHg) | 88.1 ± 11.2 | 94.9 ± 12.1 | 0.207 |
| Minimum mean BP (mmHg) | 79.4 ± 10.3 | 87.7 ± 15.3 | 0.151 |
| ΔBP (minimum–rest) (mmHg) | −6.5 ± 8.3 | −7.1 ± 8.4 | 0.617 |
| Baseline rate-pressure producta | 8336 ± 1583 | 9935 ± 3147 | 0.240 |
| Symptoms during adenosine infusion | 8 (36.4 %) | 0 (0 %) | 0.036 |
| ST change during adenosine infusion | 9 (40.9 %) | 3 (33.3 %) | 0.694 |
| SRS | 1.7 ± 3.0 | 2.6 ± 4.2 | 0.834 |
| SSS | 5.5 ± 7.3 | 7.9 ± 7.9 | 0.386 |
| SDS | 3.8 ± 5.6 | 5.3 ± 6.0 | 0.372 |
| Rest MBF (ml/min/g) | 0.980 ± 0.142 | 0.965 ± 0.215 | 0.794 |
| Modified rest MBF (ml/min/g)b | 1.060 ± 0.193 | 0.901 ± 0.219 | 0.090 |
| Stress MBF (ml/min/g) | 2.279 ± 0.530 | 1.559 ± 0.517 | 0.004 |
| MFR | 2.35 ± 0.53 | 1.59 ± 0.36 | 0.001 |
| Modified MFRc | 2.20 ± 0.53 | 1.83 ± 0.74 | 0.177 |
| Rest EDV (ml) | 100.6 ± 31.1 | 129.6 ± 56.4 | 0.164 |
| Rest ESV (ml) | 36.3 ± 18.0 | 64.1 ± 43.4 | 0.139 |
| Rest EF (%) | 65.2 ± 8.9 | 55.7 ± 13.1 | 0.090 |
| Stress EDV (ml) | 113.0 ± 36.4 | 138.4 ± 56.2 | 0.231 |
| Stress ESV (ml) | 47.0 ± 23.8 | 74.2 ± 42.4 | 0.074 |
| Stress EF (%) | 60.3 ± 9.5 | 49.7 ± 9.6 | 0.003 |
| ΔEDV (stress–rest) (ml) | 12.4 ± 12.8 | 8.8 ± 6.8 | 0.500 |
| ΔESV (stress–rest) (ml) | 10.7 ± 9.8 | 10.1 ± 9.3 | 0.896 |
| ΔEF (stress–rest) (%) | −4.9 ± 5.2 | −5.9 ± 6.1 | 0.777 |
BP blood pressure, SRS summed rest score, SSS summed stress score, SDS summed differential score, MBF myocardial blood flow, MFR myocardial flow reserve, EDV end-diastolic volume, ESV end-systolic volume, EF ejection fraction
aRate-pressure product = HR × systolic BP
bModified rest MBF = rest MBF × (8800/rate-pressure product)
cModified MFR = stress MBF/modified rest MBF
Fig. 1Linear regression analyses between heart rate (HR) ratio and quantitative values of remote regions. There was a good correlation between HR response to adenosine and myocardial flow reserve of remote regions
Multiple stepwise regression analysis with stepping method criteria of probability of F to enter <0.05 and to remove >0.10
| Variable | Standardized coefficients (β) |
|
|---|---|---|
| HR ratio | 0.480 | 0.003 |
| Dyslipidemia | −0.329 | 0.033 |
| Brinkman index | −0.308 | 0.045 |
Independent variables (p < 0.05) are listed
Diagnostic ability of visual assessment in 13N-ammonia PET studies for myocardial ischemia in normal and reduced HR response groups (>50 % stenosis on CAG was considered as a gold standard)
| Sensitivity | Specificity | PPV | NPV | |
|---|---|---|---|---|
| Normal HRR | 70.8 % | 92.9 % | 85.0 % | 84.8 % |
| Reduced HRR | 62.5 % | 84.2 % | 62.5 % | 84.2 % |
HRR heart rate response, PPV positive predictive value, NPV negative predictive value